Vaccine Contract Manufacturing Market to Reach $5.93 Billion by 2029 | Key Drivers and Future Outlook
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Vaccine Contract Manufacturing Market?
The market size for vaccine contract manufacturing has seen a significant surge recently. It is projected to swell from $3.58 billion in 2024 to $3.93 billion in 2025, marking a compound annual growth rate (CAGR) of 9.7%. This increase in the past years can be traced back to traditional limitations in vaccine manufacturing, heightened demand for vaccines due to global disease spreads, regulatory approval supporting contract manufacturing, the escalating intricacy in the production of vaccines, as well as a dramatic increase in vaccine research and development.
What Growth Rate Is Forecasted for the Vaccine Contract Manufacturing Market by 2029?
The market size for vaccine contract manufacturing is set to experience accelerated expansion in the upcoming years, with predictions pointing to a growth to $5.93 billion by the year 2029, marking a compound annual growth rate (CAGR) of 10.8%. The principal reasons stimulating growth throughout the forecast period include an intensifying focus on being prepared for pandemics, a surge in outsourcing within the pharmaceutical manufacturing sector, the growth of biopharmaceutical establishments, fast-tracked vaccine production timelines, and worldwide efforts to ensure vaccine availability. Key trends projected for the forecast interval incorporate the assimilation of single-use technologies in the manufacturing process, the emergence of personalized medicine for vaccine development, the growth of mRNA and viral vector vaccines, the adoption of continuous manufacturing procedures, and the broadening of fill-finish services.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12216&type=smp
Which Key Companies Are Shaping the Future of the Vaccine Contract Manufacturing Market?
Major companies operating in the vaccine contract manufacturing market include Pfizer Inc, Johnson & Johnson, AbbVie Inc., Sanofi, GlaxoSmithKline, Merck KGaA, Fujifilm Holdings Corporation, Moderna, BioNTech, GSK Vaccines, AstraZeneca PLC, Ajinomoto Co. Inc., Icon plc, Lonza Group AG, Cytiva, Catalent Inc., Charles River Laboratories International Inc., Serum Institute of India Pvt. Ltd, Samsung Biologics, WuXi Biologics, Novavax, Sinovac Biotech, Emergent BioSolutions Inc., Albany Molecular Research Inc., Soligenix Inc., Bio Farma, Curia Global Inc., Hualan Biological Engineering, BioMARC, Bavarian Nordic A/S, AGC Biologics, IDT Biologika GmbH, Bharat Biotech, Goodwin Biotechnology Inc., Biofabri S.L
Which Factors Are Driving Demand in the Vaccine Contract Manufacturing Industry?
The expansion of the vaccine contract manufacturing market is anticipated to be fueled by rising initiatives promoting vaccinations. These vaccinations are a simple, effective, and safe mechanism to prevent infectious diseases from spreading, strengthening the immune system and increasing resilience against infections. The augmentation of these initiatives can stimulate enhancement and progression in various vaccine manufacturing procedures, thereby supporting vaccine contract manufacturing. As an illustration, in November 2022, the U.S. Department of Health and Human Services, a US government organ at the cabinet level, divulged a new initiative of $350 million for HRSA-supported health establishments to amplify the volume of COVID-19 vaccines in their respective communities, focusing particularly on underserved individuals. Consequently, the surge in initiatives promoting vaccinations is propelling the expansion of the vaccine contract manufacturing market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12216&type=smp
How Is the Vaccine Contract Manufacturing Market Segmented by Several Divisions?
The vaccine contract manufacturing market covered in this report is segmented –
1) By Service Type: Fill-Finish, Bulk Product
2) By Vaccine Type: Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines
3) By Process: Downstream, Upstream
4) By Scale Of Operation: Preclinical, Clinical, Commercial
5) By End-Use: Human Use, Veterinary
Subsegments:
1) By Fill-Finish: Aseptic Fill-Finish, Lyophilization, Vial Filling, Syringe Filling
2) By Bulk Product: Cell Culture, Microbial Fermentation, Antigen Production, Buffer Preparation
What are the Emerging Market Trends Driving the Growth of the Vaccine Contract Manufacturing Industry?
Collaborative efforts are becoming an increasingly popular trend within the vaccine contract manufacturing sector. To maintain their standing in the market, major players are forming alliances with other companies within the same industry. For example, in January 2023, Vaxxas, an Australian biotech firm specializing in innovative needle-free vaccination methods, teamed up with the Norway-based Coalition for Epidemic Preparedness Innovations. This partnership was arranged to fund and supervise the creation of new vaccines and help advance Vaxxas’ needle-free vaccine patch delivery technology which could potentially eliminate the need for frozen storage of mRNA vaccines. Additionally, in October 2024, LenioBio, a German biotech company, joined forces with ReciBioPharm, a US-based contract development and manufacturing company, in order to boost their protein production capabilities and hasten the process of producing vaccines. This partnership is in line with LenioBio’s strategy to broaden the reach of its CEPI-financed project aimed at demonstrating the effectiveness and efficiency of its proprietary ALiCE protein expression technology for the generation of vaccine-related proteins suitable for clinical trials.
Access The Full Report Here:
Which Regions Are Driving Growth in the Vaccine Contract Manufacturing Market?
North America was the largest region in the vaccine contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the vaccine contract manufacturing market report forecast period. The regions covered in the vaccine contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12216
This Report Delivers Insight On:
1. How big is the vaccine contract manufacturing market, and how is it changing globally?
2. Who are the major companies in the vaccine contract manufacturing market, and how are they performing?
3. What are the key opportunities and risks in the vaccine contract manufacturing market right now?
4. Which products or customer segments are growing the most in the vaccine contract manufacturing market?
5. What factors are helping or slowing down the growth of the vaccine contract manufacturing market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
